pharmaphorum Podcast

The race to develop innovative products and supply chain solutions

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and SVP and international managing director of Alloga Europe and ICS, Chris Williams. The topic of discussion centres around considerations and challenges when it comes to launching a biopharmaceutical product in Europe.

The smart-design evolution of the laboratory space

In this penultimate instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Bobby Savarese, senior principal and business development director at Unispace Life Sciences, exploring how laboratory space requirements have changed since the pandemic.

Investing in the gleams of positivity and hope for life sciences innovation

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.

Looking to the future of UK medical device exports

In this second of our festive podcast series, the pharmaphorum podcast welcomed Brandon Medical CEO Keith Jackson and the Association of British HealthTech Industries (or ABHI) director of communications, Jonathan Evans, to discuss UK medical device exports, including a particular recent strategic APAC partnership and the general and ongoing representation of industry innovation to stakeholders including government, NHS, and regulators.

Exploring the reasons behind increasing burdens on clinical research sites

In the first of a five-part festive instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Advarra’s chief product officer, Elisa Cascade, about the reasons behind increasing burdens on clinical research sites over the last five years.

An investor’s perspective on bio and tech

In today’s episode of the pharmaphorum podcast, host Jonah Comstock sits down for a wide-ranging conversation with Artem Trotsyuk, an investor with LongeVC. His fund focused on therapeutics, diagnostics, and life sciences infrastructure plays.

Why digital therapeutics (DTx) are effective and safe, but not being prescribed

In a new episode of the pharmaphorum podcast, host Nicole Raleigh welcomes Joel Morse, CEO and co-founder of Curavit Clinical Research, and Andy Molnar, CEO of the Digital Therapeutics Alliance (DTA), for a discussion on why it is that digital therapeutics (DTx) are effective and safe, but not being prescribed.

AI drug discovery: Where we are and where we’re going

Today’s guest is founder and CEO of Exscientia, Andrew Hopkins, who has been named a top AI innovator by TIME and was recently appointed a lifetime fellow to both the Royal Society and the Academy of Medical Sciences in the UK.

Retaining the human element in healthcare services whilst embracing the potential of robotics

In a new episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Gavin Anderson, a man of many hats all orbiting around technology and business. Trained as a human-centric designer, Anderson helps align business strategy, purpose, and culture and tries to save the planet on the side. But, with his Academy of Robotics hat firmly in place, he’s also a player in the recent shift to try to implement AI and robotics into the healthcare setting in a drive to alleviate the burden on healthcare systems.

Bringing women’s health up to speed for 21st Century human healthcare

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with David Solomon, CEO of Mithra Pharmaceuticals, about the current women’s health landscape and what Mithra is doing on an international scale to ameliorate that.